BIOCYTE HYALURONIC FORTE 300mg 30 capsules

BIOCYTE HYALURONIC FORTE 300mg 30 capsules

DESCRIPTION

DESCRIPTION HYALURONIC FORTE 300MG

• Biocyte Hyaluronic forte 300mg is a food supplement with a high dose of hyaluronic acid.
• Food supplement whose anti-wrinkle and moisturizing action on the skin is scientifically proven.
• The multiple external aggressions that our skin undergoes promote its premature aging, dryness of the skin and the formation of wrinkles.
• HYALURONIC FORTE 300MG moisturizes the skin and improves the elasticity of the skin for a rapid anti-aging action.
• After 1 month of use, the depth of wrinkles is reduced and the elasticity of the skin is improved.
• Hyaluronic acid is considered the "cement of the skin" because it fills the mesh between the elastin and collagen fibers, giving a hydrated and plumped appearance to the skin.
• Hyaluronic acid is one of the essential "bricks" of the skin.
• It fills the mesh between the elastin and collagen fibers, giving a hydrated and plumped appearance to the skin.

EFFECTS

• - 5.8% average reduction in the depth of wrinkles
• +27% elasticity
• Significant reduction in periocular wrinkles.
• Clinical study on ingestible hyaluronic acid, taken 120 mg per day, for 1 month.

USE

• Take 1 capsule per day, with a large glass of water.
• To be taken preferably for 3 months.
• Duration of use: 30 days.

For whom?

People from 35 years old with skin losing elasticity and volume.

VPrecautions for use

A dietary supplement should not replace a varied and balanced diet and a healthy lifestyle. Do not exceed the recommended daily dose. Keep out of reach of young children. Not recommended for pregnant or breastfeeding women and children without the advice of a healthcare professional. Food supplement based on hyaluronic acid. Keep out of reach of children, not recommended for pregnant women. Do not exceed the recommended dose. Store in a cool, dry and ventilated place. To be consumed as part of a varied and balanced diet. It is important to have a healthy lifestyle.